Delivering 28% of Total Enrollment for a Phase 3 Respiratory Trial

Science 37 was the top enrolling site, contributing 28% of total enrolled patients over a 15-month window. Science 37 enrolled 44 patients per month, demonstrating an enrollment velocity 22x greater than traditional brick-and-mortar sites (averaging only 2 patients per month), and reducing the study’s overall time-to-target enrollment.